Direct Biologics, LLC

Quick facts

Phase 3 pipeline

• ExoFlo · Regenerative Medicine / Orthopedics
  ExoFlo is an exosome-based therapeutic that delivers regenerative factors to promote tissue repair and reduce inflammation.

Phase 2 pipeline

• DB-3Q

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Direct Biologics, LLC portfolio CI brief
• Direct Biologics, LLC pipeline updates RSS